
Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea™ IVT Platform
June 5th, 2024
Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea™ IVT Platform
June 5th, 2024
APDN Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Gen mRNA Production
August 23rd, 2023
APDN Granted US Patent Covering Methods of Utilizing DNA Tagged Submicron Particles for Authentication
February 25th, 2021
Applied DNA Positions LinearDNA™ Platform as the Next Generation Manufacturing Platform for Adeno-Associated Virus-based Gene Therapies Through New Patent Filing
August 17th, 2020
Applied DNA Receives Notice of Allowance on Second Patent Protecting Proprietary DNA Transfer System for Large-Scale Cotton Tagging
August 12th, 2020
Provisional Patent Application Filed for High Sensitivity COVID-19 Diagnostic Assay
March 24th, 2020
Innovation in Textiles | US Patent for CertainT in manmade cellulosic fibres
January 27th, 2020
Applied DNA Announces Issuance of U.S. Patent Protecting its CertainT® Platform in Man-Made Cellulosic Fibers and Materials
January 27th, 2020
Applied DNA awaits cellulosic tagging patent approval
October 24th, 2019